These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1367 related articles for article (PubMed ID: 26073595)

  • 41. Frequency of Need for Antitachycardia or Antibradycardia Pacing or Cardiac Resynchronization Therapy in Patients With a Single-Chamber Implantable Cardioverter-Defibrillator.
    Melles MC; Yap SC; Bhagwandien RE; Sakhi R; Szili-Torok T; Theuns DAMJ
    Am J Cardiol; 2018 Dec; 122(12):2068-2074. PubMed ID: 30340766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy.
    Brambatti M; Mathew R; Strang B; Dean J; Goyal A; Hayward JE; Long L; DeMeis P; Smoke M; Connolly SJ; Morillo CA; Amit G; Capucci A; Healey JS
    Heart Rhythm; 2015 Oct; 12(10):2148-54. PubMed ID: 26049049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS bY InCreaseD zones) trial.
    Cay S; Canpolat U; Ucar F; Ozeke O; Ozcan F; Topaloglu S; Aras D
    Am J Cardiol; 2015 May; 115(9):1235-43. PubMed ID: 25765588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Biventricular stimulation therapy in patients with heart failure and tachycardic arrhythmias. Indications--results--prospects].
    Trappe HJ
    Biomed Tech (Berl); 2002 Oct; 47(9-10):243-9. PubMed ID: 12369212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The subcutaneous implantable cardioverter defibrillator in 2019 and beyond.
    van Dijk VF; Boersma LV
    Trends Cardiovasc Med; 2020 Aug; 30(6):378-384. PubMed ID: 31610949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive factors of lead failure in patients implanted with cardiac devices.
    Aizawa Y; Negishi M; Kashimura S; Nakajima K; Kunitomi A; Katsumata Y; Nishiyama T; Kimura T; Nishiyama N; Fukumoto K; Tanimoto Y; Kohsaka S; Takatsuki S; Fukuda K
    Int J Cardiol; 2015 Nov; 199():277-81. PubMed ID: 26218183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers.
    Pettit SJ; McLean A; Colquhoun I; Connelly D; McLeod K
    Pacing Clin Electrophysiol; 2013 Dec; 36(12):1532-8. PubMed ID: 24033753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study.
    Kutyifa V; Daubert JP; Schuger C; Goldenberg I; Klein H; Aktas MK; McNitt S; Stockburger M; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e001965. PubMed ID: 26743237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
    Trappe HJ; Pfitzner P; Achtelik M; Fieguth HG
    Heart; 1997 Oct; 78(4):364-70. PubMed ID: 9404252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker.
    Porterfield C; DiMarco JP; Mason PK
    Am J Cardiol; 2015 Jan; 115(2):276-8. PubMed ID: 25465940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study.
    Köbe J; Reinke F; Meyer C; Shin DI; Martens E; Kääb S; Löher A; Amler S; Lichtenberg A; Winter J; Eckardt L
    Heart Rhythm; 2013 Jan; 10(1):29-36. PubMed ID: 23032867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator.
    Barsheshet A; Moss AJ; McNitt S; Jons C; Glikson M; Klein HU; Huang DT; Steinberg JS; Brown MW; Zareba W; Goldenberg I;
    Heart Rhythm; 2011 Feb; 8(2):212-8. PubMed ID: 21044897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early feasibility of hypoglossal nerve upper airway stimulator in patients with cardiac implantable electronic devices and continuous positive airway pressure-intolerant severe obstructive sleep apnea.
    Parikh V; Thaler E; Kato M; Gillespie MB; Nguyen S; Withrow K; Calhoun D; Soose R; Stevens D; Stevens S; Larsen C; Reddy M; Lakkireddy D
    Heart Rhythm; 2018 Aug; 15(8):1165-1170. PubMed ID: 29678782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Predictors for need of antibradycardia and antitachycardia pacing after ICD implantation : Implications for the subcutaneous ICD].
    Grett M; Christ M; Trappe HJ
    Herzschrittmacherther Elektrophysiol; 2016 Dec; 27(4):390-395. PubMed ID: 27738753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
    Borne RT; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.